Examining facial features in boys with creatine transporter deficiency
Official title: Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency
Run by National Institutes of Health Clinical Center (CC) · NCT05600946 · Data updated 2026-11-12
This study looks at photos of boys and young men with creatine transporter deficiency to see if they share certain facial features that could help doctors diagnose the condition more accurately.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years to 40 Years |
| Sex | Men only |
| Enrollment | 30 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | October 24, 2022 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT05600946 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are males aged 2 to 40 years who have a confirmed genetic mutation in the SLC6A8 gene and are enrolled in the Creatine Natural History Study.
✕Probably not a fit
Patients who have experienced status epilepticus within the last three months or have severe seizure disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate photographs of male subjects aged 2 to 40 years with creatine transporter deficiency (CTD) to identify common craniofacial features associated with the condition. The study involves collaboration with an expert in dysmorphology who will analyze the images to determine if specific dysmorphic traits are present in this population. By characterizing these features, the study seeks to improve diagnostic accuracy for CTD, which can often be confused with other disorders such as autism. Participants must have a confirmed genetic mutation in the SLC6A8 gene and provide informed consent.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for creatine transporter deficiency, aiding in earlier and more accurate identification of affected individuals.
How similar studies have gone: While this approach is focused on dysmorphology in CTD, similar studies have shown success in identifying facial features associated with other genetic disorders, suggesting potential for meaningful findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: 1. Patient is male and between 2-40 years of age, inclusive. 2. Patient has genomic confirmation of a pathologic mutation in the SLC6A8 gene. 3. Patient is able to complete study-related procedures within limitations imposed by condition under study. 4. Patients parents/guardians/caregivers must provide written consent (informed consent) to study-related procedures, and if appropriate, the patient will provide an assent. EXCLUSION CRITERIA: 1. Patient has had status epilepticus within 3 months of screening. 2. Patients has had a seizure that lasts 5 minutes or longer, and a second seizure without recovering consciousness from the first one, or if a person has repeated seizures for 30 minutes or longer. 3. Patient is unable to comply with the study procedures or has a clinical disease or laboratory abnormality that in the opinion of the investigator would potentially increase the risk of participation.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Laverne G Mensah, M.D. — Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study coordinator: Derek M Alexander
- Email: derek.alexander@nih.gov
- Phone: (301) 827-0387
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sensory Integration and Deep Pressure Therapy for Motor Coordination in Children with ASD
This study tests whether combining Sensory Integration Therapy with Deep Pressure Therapy can improve motor coordination and reduce repetitive behaviors in children aged 4–10 with autism.
-
Pupillometer screen to help identify autism in kids aged 2–4 during routine visits
A handheld pupillometer test is being tried to see if it can help identify autism in young children during regular pediatric visits.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Heart Rate Variability Biofeedback for Anxiety in Autistic Youth
This study tests a wearable heart rate variability biofeedback tool to see if it helps reduce anxiety in autistic teens.
-
Structured Sensory-Based Occupational Therapy for Children with Autism
This study tests a 12-week, 40-minute sensory-based occupational therapy program twice a week to see if it improves daily skills, sensory processing, movement, and eating in children aged 3-9 with autism.
-
Exergaming and Aerobic Exercise for Kids with Autism
This study tests whether adding exergames or aerobic exercise to a standard program helps improve sleep, movement skills, thinking skills, and brain activity in children with autism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.